Join Us by Raising Awareness for DEA’s Rescheduling of Marijuana Impact on Safety Risk for Traveling Americans

A Message from ASAP CEO

The proposed DEA reclassification of marijuana poses a major safety risk for the American traveling public.

The U.S. Drug Enforcement Administration (DEA) has proposed regulatory rulemaking to reschedule marijuana from a Schedule I to a Schedule III drug, an action that could remove marijuana from the drug testing panel for U.S. safety sensitive transportation workers, such as truck drivers, bus drivers, pilots and train operators. Without an explicit allowance for marijuana testing to deter use of safety-sensitive workers under Department of Transportation (DOT) or Nuclear Regulatory Commission (NRC), the reclassification will inadvertently create a critical safety hazard for ordinary Americans.

We ask you to join us in urging lawmakers to proceed in a cautious and prudent manner by providing an exception to continue testing for marijuana for safety-sensitive employees in Transportation and the Nuclear Industry.

Take ACTION today – Contact your Senator and U.S. Representatives!

Click Here to Contact U.S. Senators

Click Here to Contact U.S. Representatives

DEA NPRM – Schedules of Controlled Substances: Rescheduling of Marijuana

Thank you and feel free to reach out to our team with questions.

Laura Lacey Dashner, LCSW, SAP, CEO